Cargando…
Successful treatment with carboplatin and nanoparticle albumin-bound paclitaxel in a patient with pulmonary spindle cell carcinoma
INTRODUCTION: Pulmonary spindle cell carcinoma (SpCC) is a rare subtype of non-small-cell lung cancer (NSCLC) and, in general, is chemoresistance. CASE: A sixty-five year-old male patient with metastatic pulmonary SpCC was initially treated with cisplatin and docetaxel, but his disease progressed. T...
Autores principales: | Tsuji, Takahiro, Kim, Young Hak, Ozasa, Hiroaki, Sakamori, Yuichi, Nagai, Hiroki, Ajimizu, Hitomi, Yagi, Yoshitaka, Furukawa, Atsuyuki, Haga, Hironori, Mishima, Michiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501525/ https://www.ncbi.nlm.nih.gov/pubmed/26236601 http://dx.doi.org/10.1016/j.rmcr.2015.05.003 |
Ejemplares similares
-
Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report
por: SHIMA, HIROSHI, et al.
Publicado: (2016) -
Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
por: Tsuji, Takahiro, et al.
Publicado: (2017) -
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma
por: Takahashi, Akiko, et al.
Publicado: (2022) -
Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
por: Kanai, Osamu, et al.
Publicado: (2016) -
Disease Flare after Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer
por: Kuriyama, Yuka, et al.
Publicado: (2013)